✦ LIBER ✦

330 POSTER Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents against non-small cell lung cancer (NSCLC)

✍ Scribed by S. Sei; Q. Yang; J. Mussio; M. Coffey; R. Parchment; R. Shoemaker; J. Tomaszewski

Book ID: 118623958
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 61 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70335-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-967 Combination of MAPK inhibitor CI-1

P-967 Combination of MAPK inhibitor CI-1040 and conventional chemotherapeutic agents has synergistic effect in non-small cell lung cancer cell lines

✍ Molina, A.; Vicent, S.; Collantes, M.; Montuenga, L. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

353 POSTER Therapeutic potential of YM15

353 POSTER Therapeutic potential of YM155 alone and in combination with chemotherapeutics against human non-small cell lung cancer in carcinoma xenograft models

✍ K. Yamanaka; T. Nakahara; A. Kita; S. Miyoshi; A. Noda; M. Takeuchi; I. Kinoyama 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Synergistic antitumor activity of the SN

Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of non-small cell lung cancer

✍ Tatsuya Nagano; Masahiro Yasunaga; Koichi Goto; Hirotsugu Kenmotsu; Yoshikatsu K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 370 KB

## Abstract The combination therapy of CPT‐11, a prodrug of SN‐38, with S‐1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, shows a high clinical response rate in non‐small cell lung cancer (NSCLC). However, this combination causes severe toxicities such as diarrhea. Here, we invest

Mixed micelles of PEG2000-DSPE and vitam

Mixed micelles of PEG2000-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: Enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines

✍ Kanwaldeep K. Gill; Amal Kaddoumi; Sami Nazzal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 637 KB

6551 POSTER Efficacy and safety of singl

6551 POSTER Efficacy and safety of single-agent axitinib (AG-013736; AG) in patients (pts) with advanced non-small cell lung cancer (NSCLC): a phase II trial

✍ von Pawel, J.; Larson, T.; Ou, S.I.; Limentani, S.A.; Sandler, A.B.; Vokes, E.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Molecular pharmacodynamics of PM02734 (e

Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models

✍ Yi-He Ling; Miguel Aracil; José Jimeno; Roman Perez-Soler; Yiyu Zou 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 582 KB